Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study

NCT05712161 is registered in ClinicalTrials.gov with Anteris Technologies Ltd. as lead sponsor.

NCT NCT05712161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05712161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study
Lead sponsor
Anteris Technologies Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 7, 2023
Completion date
December 31, 2033
Enrollment
15 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, aortic valve calcification, severe aortic valve stenosis, symptomatic aortic stenosis